Fund profile
Tickers
HRTS
Fund manager
Total assets
$68.06 mm
Liabilities
$3.13 mm
Net assets
$64.93 mm
Number of holdings
43.00
HRTS stock data
43 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
VRTX Vertex Pharmaceuticals, Inc. | 3.95 mm | 8.68 k shares | 6.09 | Common equity | Long | USA |
AMGN AMGEN Inc. | 3.60 mm | 11.76 k shares | 5.54 | Common equity | Long | USA |
LLY Lilly(Eli) & Co | 3.45 mm | 4.21 k shares | 5.32 | Common equity | Long | USA |
Novo Nordisk A/S
|
3.29 mm | 24.42 k shares | 5.07 | Common equity | Long | Denmark |
DXCM Dexcom Inc | 2.56 mm | 21.59 k shares | 3.95 | Common equity | Long | USA |
EW Edwards Lifesciences Corp | 2.04 mm | 23.43 k shares | 3.13 | Common equity | Long | USA |
NARI Inari Medical Inc | 2.02 mm | 40.45 k shares | 3.12 | Common equity | Long | USA |
PODD Insulet Corporation | 1.95 mm | 11.02 k shares | 3.01 | Common equity | Long | USA |
MDT Medtronic Plc | 1.86 mm | 22.85 k shares | 2.86 | Common equity | Long | Ireland |
MREO Mereo Biopharma Group Plc | 1.84 mm | 533.66 k shares | 2.84 | Common equity | Long | UK |
Novartis AG
|
1.84 mm | 17.80 k shares | 2.83 | Common equity | Long | Switzerland |
CRNX Crinetics Pharmaceuticals Inc | 1.83 mm | 41.16 k shares | 2.82 | Common equity | Long | USA |
BBIO BridgeBio Pharma Inc | 1.79 mm | 63.92 k shares | 2.76 | Common equity | Long | USA |
BSX Boston Scientific Corp. | 1.79 mm | 23.66 k shares | 2.75 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals Inc | 1.77 mm | 11.95 k shares | 2.73 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 1.77 mm | 43.97 k shares | 2.72 | Common equity | Long | USA |
Chugai Pharmaceutical Co Ltd
|
1.62 mm | 53.24 k shares | 2.49 | Common equity | Long | Japan |
RCKT Rocket Pharmaceuticals Inc | 1.52 mm | 71.43 k shares | 2.35 | Common equity | Long | USA |
MASI Masimo Corp | 1.51 mm | 12.13 k shares | 2.33 | Common equity | Long | USA |
CYTK Cytokinetics Inc | 1.41 mm | 29.00 k shares | 2.17 | Common equity | Long | USA |
NTLA Intellia Therapeutics Inc | 1.38 mm | 64.45 k shares | 2.12 | Common equity | Long | USA |
First American Treasury Obligations Fund | 1.37 mm | 1.37 mm shares | 2.11 | Short-term investment vehicle | Long | USA |
WST West Pharmaceutical Services, Inc. | 1.34 mm | 4.03 k shares | 2.06 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 1.32 mm | 9.76 k shares | 2.03 | Common equity | Long | Denmark |
BMY Bristol-Myers Squibb Co. | 1.30 mm | 31.70 k shares | 2.01 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals Inc | 1.27 mm | 33.70 k shares | 1.95 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals Inc. | 1.25 mm | 54.32 k shares | 1.92 | Common equity | Long | USA |
VKTX Viking Therapeutics Inc | 1.19 mm | 19.09 k shares | 1.83 | Common equity | Long | USA |
OMCL Omnicell, Inc. | 1.14 mm | 35.00 k shares | 1.76 | Common equity | Long | USA |
MLYS Mineralys Therapeutics Inc | 1.02 mm | 80.17 k shares | 1.58 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 1.01 mm | 25.99 k shares | 1.55 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals Inc | 977.23 k | 4.14 k shares | 1.51 | Common equity | Long | USA |
KROS Keros Therapeutics Inc | 923.15 k | 19.70 k shares | 1.42 | Common equity | Long | USA |
OSCR Oscar Health Inc - Ordinary Shares | 908.94 k | 45.54 k shares | 1.40 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals Inc | 891.06 k | 37.08 k shares | 1.37 | Common equity | Long | USA |
Zealand Pharma A/S
|
868.60 k | 9.34 k shares | 1.34 | Common equity | Long | Denmark |
SLN Silence Therapeutics Plc | 701.38 k | 33.42 k shares | 1.08 | Common equity | Long | UK |
AKRO Akero Therapeutics Inc | 672.42 k | 35.73 k shares | 1.04 | Common equity | Long | USA |
TNYA Tenaya Therapeutics Inc | 590.55 k | 140.27 k shares | 0.91 | Common equity | Long | USA |
SLNO Soleno Therapeutics Inc | 489.77 k | 11.64 k shares | 0.75 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc | 385.40 k | 11.27 k shares | 0.59 | Common equity | Long | USA |
VERV Verve Therapeutics Inc | 239.28 k | 46.11 k shares | 0.37 | Common equity | Long | USA |
SKYE Skye Bioscience Inc | 184.16 k | 15.86 k shares | 0.28 | Common equity | Long | USA |